Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
iRadimed Corporation (NASDAQ: IRMD), a pivotal player in the healthcare sector, continues to capture investor interest with its innovative MRI-compatible medical devices. The company, headquartered in Winter Springs, Florida, is..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is treading the volatile waters of the biotech sector with its focus on developing oncolytic immunotherapies for cancer treatment. Headquartered in..
Investors eyeing opportunities in the healthcare sector, particularly in medical devices, may find Neuropace, Inc. (NASDAQ: NPCE) an intriguing prospect. This California-based company, specializing in innovative treatments for drug-resistant focal..
InnovAge Holding Corp. (NASDAQ: INNV) emerges as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $492.8 million, InnovAge specializes..
Beta Bionics, Inc. (NASDAQ: BBNX) stands at the forefront of medical innovation, specifically in the development of advanced solutions for diabetes management. As a commercial-stage medical device company, Beta Bionics..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) has been making waves in the healthcare sector with its focus on developing and commercializing innovative pain management medications. As a specialty pharmaceutical company, Collegium’s..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a dynamic player in the biotechnology sector, has captured the attention of investors with its impressive potential for growth and development in the healthcare industry...
Niagen Bioscience, Inc. (NASDAQ: NAGE), a dynamic player in the biotechnology sector, has captured investor attention with its promising growth potential and strategic focus on healthy aging products. Headquartered in..
Immatics N.V. (NASDAQ: IMTX), a German biotechnology company specializing in cutting-edge cancer therapies, has recently caught the attention of investors due to its notable potential upside. This clinical-stage biopharmaceutical company..
Nuvation Bio Inc. (NASDAQ: NUVB), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising oncology-focused drug pipeline. Based in New York and founded in 2018,..
Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, is gaining attention for its significant revenue growth of 38.6%. Headquartered in Teaneck, New Jersey, Phibro serves..
Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm headquartered in Waltham, Massachusetts, is attracting significant attention from investors, especially given its promising potential upside of nearly 73%. Specializing in the development..
Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, is catching the attention of investors with its significant upside potential. With a market capitalization of $803.97..
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is drawing significant attention from investors in the biotechnology sector, particularly those with an eye on innovative therapeutics for inflammatory bowel disease (IBD). With a..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is garnering significant attention from investors as analyst ratings indicate a substantial potential upside of 145%. This biopharmaceutical company, headquartered in Cambridge, Massachusetts, specializes in..
Investors with an eye on the healthcare sector may find Fulgent Genetics, Inc. (NASDAQ: FLGT) an intriguing opportunity, especially with a potential upside of 15.26% as per current analyst ratings...
Investors keen on exploring opportunities within the healthcare sector might find CareDx, Inc. (NASDAQ: CDNA) an intriguing prospect. With a significant market presence in the diagnostics and research industry, CareDx..
Nutex Health Inc. (NUTX), a rising player in the healthcare sector, is catching the eye of investors with its impressive financial metrics and significant growth potential. Operating within the medical..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a pioneering biotechnology firm with a focus on gene therapies for rare and life-threatening diseases, is currently trading at a compelling price point that suggests..
